NCT00006011: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer |
|
|
| Completed | 3 | 659 | US | Doxorubicin Hydrochloride, Cisplatin, Filgrastim, G-CSF, Nivestim, r-metHuG-CSF, Pegfilgrastim, Filgrastim SD-01, GCSF-SD01, Neulasta, Paclitaxel, Anzatax, TAX | Gynecologic Oncology Group, Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer | 03/10 | | | |
